InvestorsHub Logo
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Re: thenewmixer post# 31012

Thursday, 01/29/2015 11:45:43 AM

Thursday, January 29, 2015 11:45:43 AM

Post# of 144811
"The first preclinical study by TD2 in the U.S. that deals with the effectiveness of PharmaCyte Biotech's pancreatic cancer treatment on the accumulation of malignant ascites fluid that is often associated with the growth of abdominal cancers, including pancreatic cancer, has been completed and positive results were obtained."

http://globenewswire.com/news-release/2014/12/16/691741/10112491/en/Nuvilex-Provides-Shareholder-Update-on-Cancer-and-Diabetes-Programs.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News